Read more about the article Patient Recruitment in Clinical Trials: From Recruitment Challenges to Successful Enrollment | Insights from Lambda
Patient Recruitment in Clinical Trials - From Recruitment Challenges to Successful Enrollment - Insights from Lambda CRO

Patient Recruitment in Clinical Trials: From Recruitment Challenges to Successful Enrollment | Insights from Lambda

Bringing a new therapy to patients depends on more than scientific innovation. It depends on identifying, enrolling, and retaining the right participants within planned timelines. Yet patient recruitment remains one…

Continue ReadingPatient Recruitment in Clinical Trials: From Recruitment Challenges to Successful Enrollment | Insights from Lambda
Read more about the article Centralized Imaging Review in Multicenter Clinical Trials: Enabling Consistent and Reliable Endpoint Evaluation
Centralized Imaging Review in Multicenter Clinical Trials - Lambda CRO

Centralized Imaging Review in Multicenter Clinical Trials: Enabling Consistent and Reliable Endpoint Evaluation

Medical imaging has become an essential component of modern clinical trials, supporting efficacy assessments, safety evaluations, and regulatory decision-making across therapeutic areas such as oncology, ophthalmology, Gastroenterology and musculoskeletal disorders.…

Continue ReadingCentralized Imaging Review in Multicenter Clinical Trials: Enabling Consistent and Reliable Endpoint Evaluation
Read more about the article Six Months of Pharmacovigilance Excellence in 2026: Delivering Global Drug Safety with Quality and Compliance
Pharmacovigilance Milestones 6 months H1 2026

Six Months of Pharmacovigilance Excellence in 2026: Delivering Global Drug Safety with Quality and Compliance

Pharmacovigilance Beyond Compliance Pharmacovigilance is no longer limited to meeting regulatory requirements. It has become a strategic function that enables sponsors to identify safety signals early, maintain global compliance, and…

Continue ReadingSix Months of Pharmacovigilance Excellence in 2026: Delivering Global Drug Safety with Quality and Compliance
Read more about the article From Research to Real-World Impact: Lambda’s Journey on International Clinical Trials Day
International Clinical Trials Day 2026 - Lambda Therapeutic Research CRO

From Research to Real-World Impact: Lambda’s Journey on International Clinical Trials Day

Every year on 20 May, the global clinical research community observes International Clinical Trials Day, a moment to recognize the scientific progress, collaboration, and patient participation that make medical advancement…

Continue ReadingFrom Research to Real-World Impact: Lambda’s Journey on International Clinical Trials Day
Read more about the article Biotherapeutics & Large Molecule Bioanalytical Services
Biotherapeutics & Large Molecule Bioanalytical Services

Biotherapeutics & Large Molecule Bioanalytical Services

Lambda Therapeutic Research provides comprehensive bioanalytical services for biotherapeutics and large molecules, supporting biologic and biosimilar programs across preclinical and clinical development. With extensive experience in large molecule bioanalysis, we…

Continue ReadingBiotherapeutics & Large Molecule Bioanalytical Services
Read more about the article Transdermal and Topical Products: Early Phase BA BE Study Capabilities
Transdermal and Topical Products Early Phase BA BE Study Capabilities Lambda CRO

Transdermal and Topical Products: Early Phase BA BE Study Capabilities

Lambda conducts early phase BA/BE studies for transdermal and topical products with a focus on pharmacokinetics, adhesion performance, and skin safety. Experience spans multiple molecules and dosage forms, supported by controlled application techniques and consistent study execution.

Continue ReadingTransdermal and Topical Products: Early Phase BA BE Study Capabilities
Read more about the article Accelerated Study Start for BA/BE Programs in India with CDSCO Prior Intimation Pathway (CT-05)
Accelerated Study Start for BABE Programs in India with CDSCO Prior Intimation Pathway (CT-05) Lambda CRO

Accelerated Study Start for BA/BE Programs in India with CDSCO Prior Intimation Pathway (CT-05)

The regulatory environment in 2025 was defined by consolidation, clarification, and higher expectations for execution. Across major regions, regulators focused on improving trial quality, reducing avoidable administrative burden, and enabling scientific progress while maintaining patient safety and data integrity.

Continue ReadingAccelerated Study Start for BA/BE Programs in India with CDSCO Prior Intimation Pathway (CT-05)